At the news
? BULLISHIMPACT 4/10 INSIDER-BUY filed Jun 29, 2026 at 16:20 ET
RA Capital Management, a 10% owner and director at Artiva Biotherapeutics, purchased ~32.9K shares for $292K over two days.
- RA Capital Management, a 10% owner/Director, bought 31K shares at $8.88 ($275K) on 6/25 and 1.9K shares at $8.98 ($17K) on 6/26
- Total insider purchase value: $292K
- Purchase represents ~0.12% of $242M market cap
- ARTV has 92% analyst bullish rating (4 Strong Buy, 7 Buy, 1 Hold)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access